Loading
A US charity, founded in 1991, that funds only early-phase (phase I and II) clinical trials of new cancer treatments, for cancers of all types.
Gateway for Cancer Research was founded in 1991 and describes itself as one of the only nonprofits solely dedicated to funding phase I and II clinical trials for cancers of all types, according to its about page. It states that it has supported more than 254 clinical trials and funded over $126 million in research since 1991, that more than 10,000 patients have taken part in trials it funded, and that all donations directly fund early-phase clinical research. Trials in OnCo that name it as a funder include a Cedars-Sinai study of ivermectin with immunotherapy in triple-negative breast cancer. The IRS Business Master File lists revenue of about $10 million for the tax year ending June 2025.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/